IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: Relationship with protein plasma levels and response to therapy

Pharmacogenomics

Volumn 7, Issue 5, 2006, Pages 683-695

  Tolusso, Barbara ^a   Pietrapertosa, Donatello ^a   Morelli, Alessia ^a   De Santis, Maria ^a   Gremese, Elisa ^a   Farina, Giuseppina ^a   Carniello, Siro Giorgio ^b   Del Frate, Marino ^c   Ferraccioli, Gianfranco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Sacile Hospital   (Italy)

^c Ospedale Civile di Gorizia   (Italy)

Author keywords

Drug response; Healthy controls; IL 1 gene complex; Polymorphism; Rheumatoid arthritis

Indexed keywords

CYCLOSPORIN A; HYDROXYCHLOROQUINE; INFLIXIMAB; INTERLEUKIN 1BETA; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PHARMACOGENOMICS; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; REMISSION; RHEUMATOID ARTHRITIS; TREATMENT FAILURE; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; ALLELES; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; METHOTREXATE; MIDDLE AGED; POLYMORPHISM, GENETIC; SIALOGLYCOPROTEINS;

EID: 33747128471     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.7.5.683     Document Type: Article

References (34)

1. Wordsworth BP, Stedeford J, Rosenberg WM, Bell JI: Limited heterogeneity of the HLA class II contribution to susceptibility to rheumatoid arthritis is suggested by positive association with HLA-DR4, DR1 and DRw10. Br. J. Rheumatol. 30, 176-180 (1991).
2. MacKay K, Eyre S, Myerscough A: Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum. 46, 632-639 (2002).
3. Barrera P, Faure S, Prudhomme J et al.: European genetic study on rheumatoid arthritis: is there a linkage of the interleukin-1 (IL-1), IL-10 or IL-4 genes to RA? Clin. Exp. Rheumatol. 19, 709-714 (2001).
4. Genevay S, Di Giovine F, Perneger T: Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthritis Rheum. 47, 303-309 (2002).
5. Lard LR, Boers M, Verhoeven A et al.: Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. Arthritis Rheum. 46, 899-905 (2002).
6. Padyukov L, Lampa J, Heimbürger M et al.: Genetic marker for the efficacy of tumor necrosis factor blocking therapy in rheumatoid arthritis. Ann. Rheum. Dis. 62, 526-529 (2003).
7. Mugnier B, Balandraud N, Darque A, Roudier C, Roudier J, Reviron D: Polymorphism at position -308 of the tumor necrosis factor α gene influences outcome of infliximab therapy in rheumatoid arthritis. Arthritis Rheum. 48, 1849-1852 (2003).
8. Cuchacovich M, Ferreira L, Aliste M et al.: Tumor necrosis factor-α (TNF- α) levels and influence of -308 TNF- α promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis. Scand. J. Rheumatol. 33, 228-232 (2004).
9. Fabris M, Tolusso B, Di Poi E, Assaloni R, Sinigaglia L, Ferraccioli GF: Tumor necrosis factor receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis. J. Rheum. 29, 1847-1850 (2002).
10. Dinarello CA: The biological properties of interleukin-1. Eur. Cytokine Netw. 5, 517-531 (1994).
11. Nicklin MJ, Weith A, Dugg GW: A physical map of the region encompassing the human interleukin-1-β, interleukin-1-β and interleukin-1 receptor antagonist genes. Genomics 19, 382-384 (1994).
12. Di Giovine FS, Takhsh E, Blakemore AI, Duff GW: Single base polymorphism at -511 in the human interleukin-1β gene. Hum. Mol. Genet. 1, 450-451 (1992).
13. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J: A TaqI polymorphism in the human interleukin-1 β (IL-1 β) gene correlates with IL-1 β secretion in vitro. Eur. J. Clin. Invest. 22, 396-402 (1992).
14. Tarlow JK, Blakemore AI, Lennard A et al.: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet 91, 403-404 (1993).
15. Hulkkonen J, Laippala P, Hurme M: A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 β plasma levels in healthy individuals. Eur. Cytokine Netw. 11, 251-255 (2000).
16. Kaijzel: EL, van Dongen H, Bakker AM, Breedveld FC, Huizinga TW Verweij CL: Relationship of polymorphisms of the interleukin-1 gene cluster to occurance and severity of rheumatoid arthritis. Tissue Antigens 59, 122-126 (2002).
17. Tarlow JK, Cork MJ, Clay FE et al.: Association between inteleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis. Br. J. Dermatol. 136, 147-148 (1997).
18. van der Paardt M, Crusius JB, Garcia-Gonzales MA et al.: Interleukin-1β and interleukin-1 receptor antagonist gene polymorphism in ankylosing spondylitis. Rheumatology 41, 1419-1423 (2002).
19. Mansfield JC, Holden H, Tarlow JK et al.: Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106, 637-642 (1994).
20. Arnett FC, Edworthy SM, Bloch DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315-324 (1988).
21. van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL: Development and validation of the European League Against Rheumatism response criteria in rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization (International League Agaisnt Rheumatism). Arthritis Rheum. 39, 34-40 (1996).
22. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 16, 1215 (1988).
23. Kanemoto K, Kawasaki J, Miyamoto T, Obayashi H, Nishimura M: Interleukin (IL)-1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann. Neurol. 47, 571-574 (2000).
24. Hurme M, Santilla S: IL-1 receptor antagonist (IL-1 R α) plasma levels are co-ordinately regulated by both IL1-R α and IL-1β genes. Eur. J. Immunol. 28, 2598-2602 (1998).
25. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68, 978-989 (2001).
26. Stephens M, Sheet P: Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am. J. Hum. Genet. 76, 449-462 (2005).
27. Excoffier LG, Schneider S: Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evolutionary Bioinformatics Online (accepted) (2005).
28. Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG: Interleukin-1 receptor antagonist gene polymorphism and rheumatoid arthritis. Rheumatol. Int. 24, 133-136 (2004).
29. Cantargel A, Navaux F, Loubet-Lescouliè P et al.: Interleukin-1 β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphism. Relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum. 42, 1093-1100 (1999).
30. Cvetkovic TJ, Wallberg-Jonsson S, Stegmayr B, Rantapala-Dahlqvist S, Lefvert AK: Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-α, IL-1β, IL-IRa genes. J. Rheumatol. 29, 212-219 (2002).
31. Carreira PE, Gonzales-Crespo MR, Ciruelo E et al.: Polymorphism of the inerleukin-1 receptor antagonist gene. A factor in susceptibility to rheumatoid arthritis in Spanish population. Arthritis Rheum. 52, 3015-3019 (2005).
32. Gabay C, Smith MF, Eidlen D, Arend WP: Interleukin 1 receptor antagonist (IL-1Ra) is an acute phase protein. J. Clin. Invest. 199, 2930-2940 (1997).
33. Vamvakopoulos J, Green C, Metcalfe S: Genetic control of IL-1β bioactivity through differential regulation of the IL-1 receptor antagonist. Eur. J. Immunol. 32, 2988-2996 (2002).
34. Santilla S, Savinainen K, Hurme M: Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand. J. Immunol. 47, 195-198 (1998).